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Molecular chaperones: Avoiding the crowd
R. John Ellis
The involvement of two types of molecular chaperone in
folding newly synthesized proteins can be rationalized in
terms of the crowded nature of the intracellular
environment. Recent work sheds light on how these
chaperones recognise their substrates and protect them
from the problems of macromolecular crowding.
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One of the criticisms that can be made of biochemistry is
the tendency of some practitioners to assume too readily
that interactions observed in their test tubes are directly
relevant to what happens inside the living cell. A major
difference between cells and test tubes is that the intracel-
lular environment is highly crowded because of the high
concentration of macromolecules — of the order of
200–400 mg ml–1 of protein and RNA — that it contains.
Biochemical studies, by contrast, are commonly made
using highly dilute solutions. This difference matters,
because one effect of crowding is to increase the thermo-
dynamic activities of macromolecules by several orders of
magnitude, prompting the suggestion that “biochemical
rates and equilibria in a living organism may bear scant
resemblance to those measured in a bath of solvent” [1].
This effect on thermodynamic activity results simply from
the fact that the concentration of macromolecules inside
cells is so high that a significant fraction of the volume is
physically occupied by macromolecules, and so is unavail-
able to other macromolecules. Theory predicts that the
thermodynamic activity of each macromolecular species in
a crowded environment exceeds the activity of the same
species in dilute solution, while experimentation shows
that the ratio of thermodynamic activity to concentration
— the activity coefficient  — for a spherical protein of 30
nm radius inside Escherichia coli is in the range 100–1000,
depending on the effective specific volume assumed for
the background macromolecules [2]. Thus the association
constant for two proteins that are interacting inside the
cell is greater than that measured for the same proteins
interacting in the test tube.
There exists a well developed biophysical theory of macro-
molecular crowding, but to date its impact on biochemistry
has been largely confined to studies of DNA replication [1].
Recent reports show the importance of considering this
crowding phenomenon when trying to understand why the
folding of some polypeptides inside cells involves two dis-
tinct types of molecular chaperone (reviewed in [3–5]).
Two types of chaperone
These two types of molecular chaperone can for brevity be
called small and large [5]; each type has a distinct function
[3,4]. Small chaperones of the stress protein DnaJ and
DnaK (Hsp70) families bind as monomers of 40 kDa and
70 kDa, respectively, to short extended runs of hydropho-
bic residues as they appear on elongating nascent polypep-
tide chains.This binding is transient, being regulated by
slow ATP hydrolysis by the DnaK component, and serves
both as a delaying device to prevent premature folding
before a complete folding unit has been synthesized, and
as an anti-aggregation device to prevent interaction with
hydrophobic residues on adjacent nascent chains.
Release of these small chaperones leaves the polypeptide
chain in an unfolded state until a sufficient length of chain
to fold into a domain has been synthesized; consecutive
domains may fold before the chain is complete. If these
folded domains expose insufficient surface hydrophobic
residues to cause aggregation, the chain can be released
safely into the cytoplasm. In some cases, however, a domain
— especially one that folds slowly — adopts a partially
folded compact intermediate state, or ‘molten globule’, that
exposes sufficient surface hydrophobic residues to run the
risk of aggregating with either adjacent domains or domains
in similar compact states released from the same or nearby
polysomes. This problem is likely to affect only a subset of
chains that complete their folding post-translationally.
The risk of aggregation is greatly increased by the effect
of macromolecular crowding, as aggregation is a high order
reaction. The concentration of ribosomes inside E. coli is
estimated to be about 30 µM; as at any one time most
ribosomes are active in protein synthesis, the concentra-
tion of nascent chains will also be about 30 µM, or almost
1 mg ml–1 for a 30 kDa chain. But the effect of crowding is
predicted to increase the effective concentration to
3–30 mM or 100–1000 mg ml–1! Protein chemists studying
the refolding of pure denatured proteins in the test tube
commonly reduce the protein concentration to below
1 mg ml–1 to avoid the problem of aggregation. The cell
cannot do this, nor can it use the small chaperones for this
purpose, as they bind only to extended hydrophobic
residues. So another type of chaperone that can recognise
hydrophobic residues on the surface of molten globules is
required to act as an anti-aggregation device specific for
such partially folded intermediates.
Genetic evidence [6] supports the view that large chaper-
ones of the chaperonin (GroEL/ES) family [7] act to
prevent protein aggregation inside an E. coli cell. Each
molecule of the oligomeric chaperonin 60 component —
GroEL, of mass about 805 kDa — contains two large
central cavities, one at each end of the barrel-shaped mol-
ecule. Each GroEL cavity is lined by the apical domains
of seven ATPase subunits, which bind to hydrophobic
patches on the surface of one molten globule. This non-
covalent interaction prevents the bound molten globule
from aggregating with other molten globules. In vitro
experiments suggest that a side effect of this anti-aggrega-
tion role is the partial unfolding of  non-aggregated chains
that have become kinetically trapped in misfolded confor-
mations, thus allowing such chains another chance to fold
correctly [8]. Unlike its anti-aggregation role, however,
there is no evidence as yet that the unfolding effect of the
chaperonin is important in vivo.
Having prevented aggregation, the chaperonin must now
contrive to allow the molten globule to fold further to the
point where it can be safely released into the cytoplasm.
This is achieved by the binding to one end of the chaper-
onin 60 of the other large chaperone, chaperonin 10 —
GroES, of mass about 98 kDa. This binding results in the
the release of the molten globule into the central cavity of
chaperonin 60 that is capped by chaperonin 10. This
capping physically prevents the released globule from dif-
fusing into the cytoplasm, which it would otherwise do at
a rate much faster than the rate of folding [3,4,9]. 
Inside this enclosed cavity, which I have termed an
Anfinsen cage [9], folding proceeds for a time set by an
ATPase timer that releases the chaperonin 10 cap. This
time is about 10 seconds at 37°C, or about half the time it
takes to synthesize the average polypeptide inside E. coli.
This makes sense as, in a rapidly growing cell, protein
folding must keep pace with protein synthesis if partially
folded intermediates prone to aggregation are not to accu-
mulate. The protein is then free to either diffuse into the
cytoplasm or to rebind to the apical domains if sufficient
hydrophobic residues are still exposed, so that another
round of folding is necessary.
Uncertainties 
Two questions about the above view of protein folding in
the cell have been under recent scrutiny. Firstly, what is the
structural basis for the difference in specificity between the
small and the large chaperones? Secondly, what is the bio-
logical significance of the in vitro observation that each
oligomer of chaperonin 60 binds only one oligomer of chap-
eronin 10, so that molten globules bound to cavities not
capped by chaperonin 10 are released into the free solution
before rebinding to another molecule of chaperonin 60 [10]?
Recent papers address both these problems. 
The crystal structure of the two domain peptide-binding
unit of DnaK from E. coli has been determined to 2 Å
resolution [11]. This unit contains a synthetic heptapep-
tide (sequence NRLLLTG) bound in extended confor-
mation through a channel defined by loops extended from
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Figure 1
Comparison of the peptide binding site in the small chaperone DnaK
with that in the large chaperone GroEL. (a) A ribbon diagram of DnaK
peptide binding domain, with peptide (pink) bound in a channel formed
by loops — L1,2 and L3,4 — of the β sandwich and capped by an α-
helical domain. The red arrow indicates the point at which the long αB
helix kinks up in one of the two known crystal forms. The amino-
terminal residues can take up either of two alternative conformations,
the second (N′) being shown in blue-green. The opening of the peptide
binding cleft in the β sheet subdomain is seen from the side, with the
long axis of the cleft perpendicular to the plane of the page. (Image
generously provided and prepared by Wayne Hendrickson and
Xiaotian Zhu.) (b) Ribbon diagram of the isolated apical domain of
GroEL showing the amino-terminal heptapeptide tag (labelled –1 to –7
and coloured red) interacting with the neighbouring molecule in the
crystal lattice. (Graphic kindly provided by Ashley Buckle; adapted
from [12].)
a β sandwich subdomain (Figure 1a). Binding interactions
centre on a central leucine that is completely buried in a
deep pocket. The peptide interacts with the DnaK
peptide-binding unit through many van der Waals con-
tacts made by its side chains, as well as through seven
main-chain hydrogen bonds and additional main-chain van
der Waals contacts. 
Adjacent to the peptide-binding channel in DnaK is a set
of α helices that is interpreted to act as a flexible lid to
encapsulate the bound peptide. This interpretation is
based on conformational differences seen in this subdo-
main in two different crystal forms, and can be rationalized
in terms of the need to prevent the bound hydrophobic
residues from interacting with similar residues in adjacent
peptides. In this respect, peptide binding to DnaK is dif-
ferent from the binding of peptides to major histocompati-
bility complex (MHC) molecules, where the peptide lies
in a open groove so as to be available for antigen presenta-
tion. Zhu et al. [11] suggest that the helical lid domain is
closed when ADP is bound, but opens to allow peptide
release in the ATP-bound state.
The crystal structure of the isolated apical domain of E. coli
GroEL has been determined to 1.7 Å resolution [12]. Like
the complete protein, this domain binds and releases
molten globules, but it lacks the cavities of the intact
oligomer, so that the folding of released polypeptide chains
takes place in free solution rather than inside an Anfinsen
folding cage. By producing this fragment, Buckle et al. [12]
have essentially reversed evolution by converting a large
chaperone into a small chaperone; for this reason their use
of the term ‘mini-chaperone’ is appropriate.
The apical domain was made with an additional amino-
terminal tag of seventeen residues, six of which are
histidines. Seven of the other residues — sequence
GLVPRGS — were resolved in the structure and bind to
nonpolar residues in a neighbouring domain in the
crystal. Buckle et al. [12] suggest that this mimics the
binding of a natural peptide substrate to an intact
oligomer, but this conclusion awaits confirmation. The
binding residues in the fragment are nonpolar, and are
located in a shallow cleft between α helices H8 and H9
and in an adjacent surface formed by the packing
between helix H9 and a neighbouring loop (Figure 1b).
Most binding interactions are nonpolar, with four hydro-
gen bonds. Earlier mutational studies identified five of
the binding residues as required for peptide binding, but
also identified another four residues not seen in this
study, so the binding site for natural peptide substrates
probably extends further. The peptide binding site in
GroEL is known to be flexible, so Buckle et al. [12]
propose that it can accommodate a wide range of side
chains as a result of movements of helices H8 and H9
and the nearby loops.
One difference between the peptide binding site of
GroEL and that of DnaK is the absence of anything in the
former corresponding to the latter’s flexible lid. This dif-
ference can be rationalised on the basis that, in a cell, the
apical domain of GroEL forms part of the inner surface of
the folding cage, so peptides bound in this region are
already sequestered from contact with peptides on other
molten globules outside the cage. Once released from the
apical domains, however, molten globules will diffuse
rapidly into the cytoplasm from cavities that are uncapped
by GroES. This effect has been observed in vitro [10], so
how do cells circumvent this danger? 
It is possible to mimic in vitro the crowded environment
characteristic of cytoplasm by adding high concentrations
of synthetic macromolecules such as dextran 70 and Ficoll
[1]. The addition of such crowding agents to GroEL/ES-
assisted protein folding mixtures almost completely abol-
ishes the release of molten globules from uncapped cavi-
ties and their rebinding to other GroEL molecules [13].
The same result is observed if cytoplasmic extracts from
Xenopus eggs are added, provided that the final concentra-
tion of protein is at least 200 mg ml–1 [13]. These observa-
tions suggest that, in the cell, a released molten globule
rebinds to the same GroEL molecule that has just
released it; this rapid recapture reduces the probability of
aggregation with other molten globules. An additional
effect of crowding is to reduce the diffusion of proteins by
about one order of magnitude [1]. This reduction will also
contribute to solving the essential problem that folding
proteins face — how to avoid the crowded cytoplasm until
their aggregation-prone surfaces are safely buried.
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